Arkolith/Insider Trading/VKTX/Form 4

Foehr Matthew W

DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Jan 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$562K
Net Open-Market Flow
-$562K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Grant(A)3K—$0135K
Jan 2, 2026Option exercise(M)16K$3.33$53K148K
Jan 2, 2026Sell(S)16K$35.11$562K132K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Option exercise(M)16K—$00
Jan 2, 2026Grant(A)20K—$020K

Transaction Codes

A
Grant / award
M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-003109) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML